Integrated Multi-Omics Investigation of Gypenosides’ Mechanisms in Lowering Hepatic Cholesterol
Biomolecules · 21.08.2025 · 15 (8) · 1205
DOI: 10.3390/biom15081205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.08.2025. Verfasst von Qin Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Engineering Research Center of Industrial Key-Technology for Dendrobium Nobile, Guizhou Engineering Research Center for Orchid Medicinal Plan…. Hauptthemen laut MEDLINE: Liver, Cholesterol, Hypercholesterolemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Engineering Research Center of Industrial Key-technology for Dendrobium Nobile, Department of Science and Technology of Guizhou Province.
Abstract (Originalsprache)
(1)
Objective
This study aimed to systematically elucidate the molecular mechanisms by which gypenosides (GP), a major active component of Gynostemma pentaphyllum, ameliorate hypercholesterolemia by modulating the hepatic steroidogenesis pathway, and to identify key therapeutic targets. (2)
Methods
We established a high-fat diet (HFD)-induced hypercholesterolemia (HC) mouse model and performed GP intervention. An integrated multi-omics approach, combining transcriptomics and proteomics, was utilized to comprehensively analyze GP’s effects on the expression of genes and proteins associated with hepatic cholesterol synthesis, transport, and steroid hormone metabolism. (3)
Results
HFD induced significant dysregulation, with 48 steroidogenesis pathway-related genes and 35 corresponding proteins exhibiting altered expression in HC mouse livers. GP treatment remarkably reversed these HFD-induced abnormalities, significantly restoring the expression levels of 42 genes and 14 proteins. Multi-omics integration identified seven critical genes/proteins—Cyp3a25, Fdft1, Tm7sf2, Hmgcs1, Fdps, Mvd, and Pmvk—that were consistently and significantly regulated by GP at both transcriptional and translational levels. Furthermore, correlation analyses demonstrated that Cyp3a25 was significantly negatively correlated with serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), whereas Fdft1, Tm7sf2, Hmgcs1, Fdps, Mvd, and Pmvk showed significant positive correlations. (4)
Conclusions
GP effectively ameliorates cholesterol dyshomeostasis through a multi-targeted mechanism in the liver. It inhibits endogenous cholesterol synthesis by downregulating key enzymes (Hmgcs1, Fdft1, Pmvk, Mvd, Fdps, Tm7sf2), promotes cholesterol efflux and transport (upregulating Abca1, ApoB), and accelerates steroid hormone metabolism (upregulating Cyp3a11, Cyp3a25). These findings provide robust scientific evidence for the development of GP as a safe and effective novel therapeutic agent for hypercholesterolemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Engineering Research Center of Industrial Key-Technology for Dendrobium Nobile, Guizhou Engineering Research Center for Orchid Medicinal Plant Breeding and Efficient Application, Zunyi Medical University, Zunyi…
ORCID-Profile: Jian Xie
Förderung
- National Natural Science Foundation of China
- Guizhou Engineering Research Center of Industrial Key-technology for Dendrobium Nobile
- Department of Science and Technology of Guizhou Province
- Science and Technology Fund of Guizhou Provincial Health Commission
- Graduate Fund of Guizhou Province
- Guizhou University Student Innovation Fund
Zitieren
APA
Jiang, Q., Yang, T., Yang, H., Chen, Y., Xiong, Y., Qin, L., Zhang, Q., Tan, D., Wu, X., Zhao, Y., Xie, J., & He, Y. (2025). Integrated Multi-Omics Investigation of Gypenosides’ Mechanisms in Lowering Hepatic Cholesterol. Biomolecules, 15(8), 1205. https://doi.org/10.3390/biom15081205
Vancouver
Jiang Q, Yang T, Yang H, Chen Y, Xiong Y, Qin L, et al. Integrated Multi-Omics Investigation of Gypenosides’ Mechanisms in Lowering Hepatic Cholesterol. Biomolecules. 2025;15(8):1205. doi:10.3390/biom15081205
BibTeX
@article{Jiang2025,
author = {Jiang, Qin and Yang, Tao and Yang, Hao and Chen, Yi and Xiong, Yuan and Qin, Lin and Zhang, Qianru and Tan, Daopeng and Wu, Xingdong and Zhao, Yongxia and Xie, Jian and He, Yuqi},
title = {Integrated Multi-Omics Investigation of Gypenosides’ Mechanisms in Lowering Hepatic Cholesterol},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {8},
pages = {1205},
doi = {10.3390/biom15081205}
}
EUVIMED